References
- Basir G. S., O W. S., So W. W., Ng E. H., Ho P. C. Evaluation of cycle-to-cycle variation of endometrial responsiveness using transvaginal sonography in women undergoing assisted reproduction. Ultrasound in Obstetrics & Gynecology 2002; 19: 484–489
- Ben-Nun I., Jaffe R., Fejgin M. D., Beyth Y. Therapeutic maturation of endometrium in in-vitro fertilization and embryo transfer. Fertility & Sterility 1992; 57: 953–962
- Coskun S., Roca G. L., Elnour A., al Mayman H., Hollanders J. M., Jaroudi K. A. Effect of reducing insemination time in human in vitro fertilization and embryo development by using sibling oocytes. Journal of Assisted Reproduction & Genetics 1998; 15: 605–608
- Edwards R., Steptoe P. Establishing full-term human pregnancies using cleavage embryos grown in vitro. British Journal of Obstetrics & Gynaecology 1980; 87: 737–756
- Elefant E., Biour B., Blumburg-Tick J., Roux C., Thomas F. Administration of GnRH agonist during pregnancy: Follow-up of 28 pregnancies exposed to triptorelin. Fertility & Sterility 1995; 63: 1111–1113
- Hughes E. G., Fedorkow D. M., Daya S., Sagle M. A., Van de Koppel P., Collins J. A. The routine use of gonadotropin-releasing hormone agonist prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertility & Sterility 1992; 58: 888–896
- Hutchinson-Williams K. A., DeCherney A. H., Lavy G., Diamond M. P., Naftolin F., Lunenfeld B. Luteal rescue in in vitro fertilization – embryo transfer. Fertility & Sterility 1990; 53: 495–501
- Kovacs P., Matyas S., Boda K., Kaali S. G. The effect of endometrial thickness on IVF/ICSI outcome. Human Reproduction 2003; 18: 2337–2341
- Lambalk C. B., Homburg R. GnRH agonist for luteal support in IVF? Setting the balance between enthusiasm and caution. Human Reproduction 2006; 21: 2580–2582
- Macklon N. S., Fauser B. C. Impact of ovarian hyperstimulation on the luteal phase. Journal of Reproduction & Fertility 2000; 55(Suppl.)101–108
- Nosarka S., Kruger T., Siebert I., Grove D. Luteal phase support in in-vitro fertilization: A meta-analysis of randomized trials. Gynecologic & Obstetric Investigation 2005; 60: 67–74
- Pirard C., Donnez J., Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: Results of a pilot study. Human Reproduction 2006; 21: 1894–1900
- Porter R. N., Smith W., Craft I. L., Abdulwahid N. A., Jacobs H. S. Induction of ovulation for in vitro fertilization using buserelin and gonadotropins. Lancet 1984; Dec 1;2(8414)1284–1285
- Pritts E. A., Atwood A. K. Luteal phase support in infertility treatment: A meta-analysis of the randomized trials. Human Reproduction 2002; 17: 2287–2299
- Raga F., Casan E. M., Kruessel J. S., Wen Y., Huang H. Y., Nezhat C., Polan M. L. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biology of Reproduction 1998; 59: 661–669
- Tavaniotou A., Albano C., Smitz J., Devroey P. Impact of ovarian stimulation on corpus luteum function and embryonic implantation. Journal of Reproductive Immunology 2002; 55: 123–130
- Tesarik J., Hazout A., Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Human Reproduction 2004; 19: 1176–1180
- Tesarik J., Hazout A., Mendoza-Tesarik R., Mendoza N., Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist and antagonist-treated ovarian stimulation cycles. Human Reproduction 2006; 21: 2572–2579
- Zhang X., Chen C. H., Confino E., Barnes R., Milad M., Kazer R. R. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization – embryo transfer. Fertility & Sterility 2005; 83: 336–340